Optimal Management of Severe Plaque Form of Psoriasis

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.6, Iss.5, 2005-01, pp. : 283-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efalizumab: A Review of its Use in the Management of Chronic Moderate-to-Severe Plaque Psoriasis

By Frampton James E. Plosker Greg L.

American Journal of Clinical Dermatology, Vol. 10, Iss. 1, 2009-01 ,pp. : 51-72

Adis International

Access to resources Recommend Favorite

Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis†

By Croxtall Jamie D.

American Journal of Clinical Dermatology, Vol. 13, Iss. 2, 2012-04 ,pp. : 135-137

Adis International

Access to resources Recommend Favorite

Etanercept: A Review of its Use in the Management of Plaque Psoriasis and Psoriatic Arthritis

By Goldsmith David R. Wagstaff Antona J.

American Journal of Clinical Dermatology, Vol. 6, Iss. 2, 2005-01 ,pp. : 121-136

Adis International

Access to resources Recommend Favorite

Adalimumab: In Plaque Psoriasis

By Croom Katherine F. McCormack Paul L.

American Journal of Clinical Dermatology, Vol. 10, Iss. 1, 2009-01 ,pp. : 43-50

Adis International

Access to resources Recommend Favorite

Briakinumab for the Treatment of Plaque Psoriasis

By Traczewski Pawel Rudnicka Lidia

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite